Nowak; Elizabeth

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nowak; Elizabeth.The latest application filed is for "autoimmune disorder treatment using rxr agonists".

Company Profile

17.10.31

Nowak; Elizabeth - West Lebanon NH
Nowak; Elizabeth - East Aurora NY US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Autoimmune Disorder Treatment Using Rxr Agonists App 20220151964 - Chandraratna; Roshantha A. ; et al.	2022-05-19
Autoimmune Disorder Treatment Using Rxr Agonists App 20220117922 - Chandraratna; Roshantha A. ; et al.	2022-04-21
Autoimmune disorder treatment using RXR agonists Grant 11,246,845 - Chandraratna , et al. February 15, 2	2022-02-15
Vista Antagonist And Methods Of Use App 20210361736 - NOELLE; Randolph J. ; et al.	2021-11-25
Autoimmune disorder treatment using RXR agonists Grant 11,166,927 - Chandraratna , et al. November 9, 2	2021-11-09
Novel VISTA-Ig constructs and the use of VISTA-Ig for Treatment of Autoimmune, Allergic and Inflammatory Disorders App 20210147521 - Noelle; Randolph J. ; et al.	2021-05-20
Autoimmune Disorder Treatment Using Rxr Agonists App 20210128504 - Chandraratna; Roshantha A. ; et al.	2021-05-06
Autoimmune Disorder Treatment Using Rxr Agonists App 20210128503 - Chandraratna; Roshantha A. ; et al.	2021-05-06
Autoimmune disorder treatment using RXR agonists Grant 10,945,976 - Chandraratna , et al. March 16, 2	2021-03-16
VISTA antagonist and methods of use Grant 10,933,115 - Noelle , et al. March 2, 2	2021-03-02
Vista-ig For Treatment Of Autoimmune, Allergic And Inflammatory Disorders App 20210032317 - Noelle; Randolph J. ; et al.	2021-02-04
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders Grant 10,745,467 - Noelle , et al. A	2020-08-18
Autoimmune disorder treatment using RXR agonists Grant 10,695,307 - Chandraratna , et al.	2020-06-30
Treatment Of Diseases By Concurrently Eliciting Remyelination Effects And Immunomodulatory Effects Using Selective Rxr Agonists App 20200163915 - Chandraratna; Roshantha A. ; et al.	2020-05-28
Autoimmune Disorder Treatment Using Rxr Agonists App 20200155489 - Chandraratna; Roshantha A. ; et al.	2020-05-21
Autoimmune Disorder Treatment Using Rxr Agonists App 20200155488 - Chandraratna; Roshantha A. ; et al.	2020-05-21
Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists Grant 10,653,650 - Chandraratna , et al.	2020-05-19
Vista Antagonist And Methods Of Use App 20200093902 - NOELLE; Randolph J. ; et al.	2020-03-26
Autoimmune disorder treatment using RXR agonists Grant 10,285,960 - Chandraratna , et al.	2019-05-14
Autoimmune Disorder Treatment Using Rxr Agonists App 20190125705 - Chandraratna; Roshantha A. ; et al.	2019-05-02
Autoimmune disorder treatment using RXR agonists Grant 10,201,512 - Chandraratna , et al. Feb	2019-02-12
Renewable Energy-based Atmospheric Water Generator App 20180371726 - Nowak; Elizabeth ; et al.	2018-12-27
Autoimmune Disorder Treatment Using Rxr Agonists App 20180263939 - Chandraratna; Roshantha A. ; et al.	2018-09-20
Autoimmune disorder treatment using RXR agonists Grant 10,034,845 - Chandraratna , et al. July 31, 2	2018-07-31
Autoimmune Disorder Treatment Using Rxr Agonists App 20180116985 - Chandraratna; Roshantha A. ; et al.	2018-05-03
Novel VISTA-Ig constructs and the use of VISTA-Ig for Treatment of Autoimmune, Allergic and Inflammatory Disorders App 20180051070 - Noelle; Randolph J. ; et al.	2018-02-22
Autoimmune Disorder Treatment using RXR Agonists App 20170056348 - Chandraratna; Roshantha A. ; et al.	2017-03-02
Vista Antagonist And Methods Of Use App 20160331803 - NOELLE; Randolph J. ; et al.	2016-11-17
VISTA-Ig for Treatment of Autoimmune, Allergic and Inflammatory Disorders App 20160318999 - Noelle; Randolph J. ; et al.	2016-11-03
Autoimmune Disorder Treatment Using RXR Agonists App 20150342917 - Chandraratna; Roshantha A. ; et al.	2015-12-03
VISTA Antagonist and Methods of Use App 20150231215 - NOELLE; Randolph J. ; et al.	2015-08-20
Autoimmune Disorder Treatment Using RXR Agonists App 20150196517 - Chandraratna; Roshantha A. ; et al.	2015-07-16
Treatment of Diseases by Concurrently Eliciting Remyelination Effects and Immunomodulatory Effects Using Selective RXR Agonists App 20150038585 - Chandraratna; Roshantha A. ; et al.	2015-02-05
Novel VISTA-Ig constructs and the use of VISTA-Ig for Treatment of Autoimmune, Allergic and Inflammatory Disorders App 20140220012 - Noelle; Randolph J. ; et al.	2014-08-07
Renewable Energy-based Atmospheric Water Generator App 20140083120 - Nowak; Elizabeth ; et al.	2014-03-27
VISTA-Ig for Treatment of Autoimmune, Allergic and Inflammatory Disorders App 20140056892 - Noelle; Randolph J. ; et al.	2014-02-27
Autoimmune Disorder Treatment Using Rxr Agonists App 20130190395 - Chandraratna; Roshantha A. ; et al.	2013-07-25
Inflammation and Autoimmune Disorder Treatment using RARa Selective Agonists App 20120238623 - Chandraratna; Roshantha A. ; et al.	2012-09-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.